Antonio Regalado
Progress in science depends on new techniques, new discoveries and new ideas, probably in that order - {Sydney Brenner}. I write about biotech @techreview
Last synced from Twitter 91d ago
Trump Tells Coronavirus, ‘I Surrender’
The president plays the climate-denial playbook on a pandemic.
As Election Nears, Trump Makes a Final Push Against Climate Science
The administration is imposing new limits on the National Oceanic and Atmospheric Administration that would undercut action against global warming.
Antonio Regalado
The covid-19 plan is also the plan for climate change.
--when it's uncertain, say it's not real
--when it's proven, say the science is in dispute
--when it's obvious, say it's too late to do anything
92d
Reactions to the National Academies/Royal Society Report on <italic toggle="yes">Heritable Human Genome Editing</italic>
The CRISPR Journal
Antonio Regalado
There's a paper out that brings > 20 nutshell reactions to the National Academy report on paths forward for germline editing (i.e. CRISPR babies)
My favorite: "An extremely expensive bridge to a remote island"
92d
More Antibody Data
Unfortunately, we're getting a dose these days of "That's why you run clinical trials". Word came Monday evening (Peter Loftus in the WSJ, and a Lilly statement) that the ACTIV-3 trial being run by the NIH has shown lack of efficacy for the...
1
Antonio Regalado
Reality check on covid drugs after Eli Lilly says its antibody does not work in sickest patients (might be too late to help).
So touted antibodies not a cure? Might still prove useful if given to high risk people as prevention
via @Dereklowe
92d
Sánchez aprueba un nuevo estado de alarma para toda España con intención de que se prolongue hasta el 9 de mayo
El nuevo decreto establece el confinamiento nocturno de las once de la noche a seis de la mañana en todo el país, con un margen para las autonomías para adelantarlo o atrasarlo una hora
Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
The world has bet the farm on vaccines as the solution to the pandemic, but the trials are not focused on answering the questions many might assume they are. Peter Doshi reports
As phase III trials of covid-19 vaccines reach their target...
The White House Chief Of Staff Said The Trump Administration Is "Not Going To Control The Pandemic"
The top Trump aide told CNN that the administration was not going to control the pandemic as coronavirus cases surge across the country.
NEW: Pence Chief of Staff Marc Short Tests Positive for Coronavirus
Vice President Mike Pence, head of the Coronavirus Task Force, has seen several staff members test positive for Covid this week.
Antonio Regalado
Staff of VP Mike Pence, head of US Coronavirus Task Force, testing positive for coronavirus.
94d
I Should Have Worn a Mask
It’s not a partisan or cultural symbol, not a sign of weakness or virtue.
1
Antonio Regalado
"When you get this disease, it hits you how easy it is to prevent. We are asked to wear cloth over our mouth and nose, wash our hands and avoid crowds... Seldom has so little been asked for so much benefit. " Chris Christie
96d
Remdesivir Just Became The First Drug Approved By The FDA To Treat COVID-19
"It is absolutely not a blockbuster drug or a miracle drug," one expert said. "We give it because we don’t have anything better."
Should You Choose Your Baby’s Eye Color?
Dr. Jennifer Doudna, a Nobel Prize recipient, talks to Kara Swisher about the power — and pitfalls — of CRISPR gene-editing technology.
Antonio Regalado
Pretty good interview by Kara Swisher with Jennifer Dounda, CRISPR Nobelist, offering a few new tidbits on CRISPR babies episodes, glass ceilings in science, etc.
97d
How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race
German biotech BioNTech SE worked on cancer treatments, and was developing an influenza vaccine with Pfizer Inc., when its founder, Ugur Sahin, led the company’s pivot to the coronavirus in January.
An angry Azar floats plans to oust FDA’s Hahn
Fights over vaccine standards have created an unbridgeable divide within HHS, officials said, but White House is unlikely to approve any changes until after the election.
Voluntário brasileiro para vacina de Oxford morre; laboratório não informa se ele recebeu imunizante
Anvisa foi notificada sobre morte de jovem de 28 anos; comitê recomendou prosseguimento dos estudos e investigações continuam
Alexey Navalny Has the Proof of His Poisoning
The Russian anti-corruption activist, who nearly died in August, talks about his recovery and his future.
Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App
Reports of "Long-COVID", are rising but little is known about prevalence, risk factors, or whether it is possible to predict a protracted course early in the disease. We analysed data from 4182 incident cases of COVID-19 who logged their symptoms...
1
Antonio Regalado
I am assembling every longcovid preprint/paper I see (e.g. no filtering). another:
"Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App
98d
Ireland becomes the first European country to reimpose a national lockdown.
1
Antonio Regalado
Rationale for "challenge trials" (where they give you the coronavirus on purpose) is evolving. No longer to see if a vaccine works, but which works best? Might be a better use the approach since comparing vaccines going to be difficult.
99d
Opinion: Cancelling Halloween is an act of ghoulish politics
This year has played nasty tricks on us. Isn’t it time for public health officials and governments to offer up some treats?
One doctor’s campaign to stop a covid-19 vaccine being rushed through before Election Day
After being released from Walter Reed National Military Medical Center on October 5, US President Donald Trump praised the doctors who treated him for covid-19 and promised that the public would soon have a vaccine against the deadly coronavirus....
Plotting a scientific path to counter COVID-19
In a global online forum Tuesday night, scientific leaders from companies developing vaccines, therapies and diagnostics to address the COVID-19 outbreak discussed opportunities for collaboration, highlighted challenges, and called for sustained...